Back to Search Start Over

Blood concentrations of clobazam and norclobazam in a lethal case involving clobazam, meprobamate and clorazepate.

Authors :
Pok PR
Mauras M
De Saint Léger MN
Kuhlmann E
Charpenel-Durat C
Navarette C
Duval ML
De Meo P
Source :
Legal medicine (Tokyo, Japan) [Leg Med (Tokyo)] 2010 Nov; Vol. 12 (6), pp. 300-4. Date of Electronic Publication: 2010 Sep 25.
Publication Year :
2010

Abstract

Clobazam is a benzodiazepine with anti-anxiety and anticonvulsant properties marketed in several countries. Norclobazam, a metabolite of clobazam, has similar pharmacological activity but weaker sedative and tranquilizing effect. The two drugs were detected by GC-MS and determined by HPLC-DAD in the samples from a postmortem case. The femoral blood concentrations of clobazam and norclobazam were 0.72 and 36 μg/mL, respectively. The concentration of the active norclobazam was very high. The sum of both clobazam and norclobazam blood concentration (36.72 μg/mL) was clearly toxic, but was not necessarily fatal. Other associated drugs concentrations were within their therapeutic ranges. Interactions due to drug association were discussed.<br /> (Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1873-4162
Volume :
12
Issue :
6
Database :
MEDLINE
Journal :
Legal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
20870445
Full Text :
https://doi.org/10.1016/j.legalmed.2010.08.002